Related Experiment Video
Updated: Jul 7, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I
Sébastien Simard1, Emilie Maurais, Caroline Gilbert
1Centre de Recherche en Infectiologie, Centre Hospitalier de l'Université Laval, Département de biologie médicale, Faculté de médecine, Université Laval, Québec, Canada.
Abstract:
It has been proposed that the systemic immune activation state seen in HIV-1-infected patients is caused by circulating microbial products such as lipopolysaccharide (LPS). Given that macrophages play a key role in HIV-1 pathogenesis, we investigated the LPS-mediated effect on HIV-1 replication in cells of the myeloid lineage. We demonstrate that LPS promotes virus gene expression in a monocytic cell line while it diminishes virus production in primary human monocyte-derived macrophages (MDM). The incapacity of LPS to drive HIV-1 production in MDM was not due to its inability to activate the ubiquitous transcription factor NF-kappaB even in virus-infected cells. Neutralization of type I interferons (IFN) with B18R, a soluble vaccinia virus-coded type I IFN receptor, significantly but not totally diminished the antiviral activity of LPS. Therefore, inhibition of HIV-1 replication in MDM treated with microbial-derived LPS resulted from the induction of type I interferons and a yet to be defined soluble factor.
Insights
Lipopolysaccharide (LPS) differentially affects HIV-1 replication in myeloid cells. While LPS boosts HIV-1 gene expression in monocytic cells, it inhibits replication in macrophages via type I interferons.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Systemic immune activation in HIV-1 infection may stem from microbial products like lipopolysaccharide (LPS).
- Macrophages are crucial in HIV-1 pathogenesis, making their response to immune stimuli significant.
Purpose of the Study:
- To investigate the impact of LPS on HIV-1 replication in myeloid lineage cells.
- To elucidate the mechanisms behind LPS-mediated effects on HIV-1 in macrophages.
Main Methods:
- Utilized a monocytic cell line and primary human monocyte-derived macrophages (MDM).
- Assessed HIV-1 gene expression and production following LPS treatment.
- Investigated NF-kappaB activation and the role of type I interferons (IFN) using B18R neutralization.
Main Results:
- LPS promoted HIV-1 gene expression in a monocytic cell line.
- LPS diminished HIV-1 production in primary human MDM, despite activating NF-kappaB.
- Neutralization of type I IFN partially reversed LPS's antiviral effect in MDM.
Conclusions:
- LPS exhibits distinct effects on HIV-1 replication depending on the myeloid cell type.
- The antiviral activity of LPS in MDM is mediated by induced type I interferons and another unidentified soluble factor.
- Understanding these differential responses is key to managing HIV-1 pathogenesis.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Inhibitors Of Virion Release
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

